 |
Anthos Therapeutics
Last updated: September 30, 2025
CEO John Glasspool
USA | Funding: $250M (+)
Website: https://www.anthostherapeutics.com/
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for high-risk cardiovascular patients.
Website: https://www.anthostherapeutics.com/
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for high-risk cardiovascular patients.
